The association with GFAP was particularly consistent, further emphasizing findings from animal models [28] and fresh-frozen human MS brain tissue [29], in which the Gas6/TAM system was associated with axonal damage, inferior ability of remyelination and higher degree of neurodegeneration. This evidence concerns the gene GAS6 and myeloid sarcoma.